Tianjin Pharmaceutical Da Ren Tang Q3 2024 Financial Analysis: 6% Net Profit Decline Amid TCM-Focused Growth Strategy
minichart
October 30, 2024
Financial Analysis Report: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited – Q3 2024 Business Overview Core Operations and Segments: Tianjin Pharmaceutical Da Ren Tang Group operates primarily in two segments: Traditional Chinese Medicine...